Vote Scores
Filings read through

Sino Biopharmaceutical Limited: how funds voted at the meeting of 5 Jun 2024

Ticker
SBMFF
Meeting
Season
year to 30 June 2024
Filers reporting
66
Ballot items
6

66 filers on Form N-PX reported votes at the Sino Biopharmaceutical Limited meeting of 5 Jun 2024. The records fall into 6 ballot items. The page lists them in ballot order: items of the company first, then proposals from security holders. Each bar shows how the reporting filers split. It is not the result of the meeting.

This meeting is in the year to 30 June 2024. The latest season on file is the year to 30 June 2026. The page of Sino Biopharmaceutical Limited has the latest meeting.

If the reporting person has not received confirmation of the actual number of votes cast prior to filing a report on Form N-PX, the numbers reported may reflect the number of shares instructed to be cast. A reporting person is not required to amend a previously filed Form N-PX report if the reporting person subsequently receives confirmation of the actual number of votes cast.

The words of the SEC. Source: Form N-PX and its instructions, Special Instructions D.5 and D.8, copied on .

The words of this site: the filer writes each filing. The SEC does not say that it checked the votes. A lender does not vote shares that are on loan. A later filing (Form N-PX/A) can replace an earlier filing, and the site uses the latest.

The figures on this page count the filers that report on Form N-PX and the shares they reported. They do not count all votes cast at the meeting.

The page gives records. It gives no investment advice and no advice on how to vote.

Season on this page: year to 30 June 2024. Filings read through . How the figures are made

The ballot

ForAgainstAbstain, withhold or otherAmber tick: the part cast against management

  1. Item 1: Director elections

    3 nominees. 73.1% of the reported votes are for. 25 filers withheld from or voted against at least one nominee.

    345 vote records from 66 filers. 12 of the 66 filers that marked the item voted against management.

    One filer reported a share count too large for the holding. The share split leaves those figures out; the counts of filers keep them. The rule

    • Positions of 29 fund families
    • For 25
    • Against 4
    • Against management 4
  2. Item 2: Audit-related items (auditor ratification)

    115 vote records from 66 filers. 0 of the 66 filers that marked the item voted against management.

    One filer reported a share count too large for the holding. The share split leaves those figures out; the counts of filers keep them. The rule

    • Positions of 29 fund families
    • For 29
  3. Item 3: CAPITAL STRUCTURE: management items

    The company's items in this category are shown together, because filers word and number them differently.

    460 vote records from 66 filers. 0 of the 66 filers that marked the item voted against management.

    One filer reported a share count too large for the holding. The share split leaves those figures out; the counts of filers keep them. The rule

    • Positions of 29 fund families
    • For 1
    • Split or no vote 28
  4. Item 4: COMPENSATION: management items

    The company's items in this category are shown together, because filers word and number them differently.

    115 vote records from 66 filers. 1 of the 66 filers that marked the item voted against management.

    One filer reported a share count too large for the holding. The share split leaves those figures out; the counts of filers keep them. The rule

    • Positions of 29 fund families
    • For 28
    • Against 1
    • Against management 1
  5. Item 5: CORPORATE GOVERNANCE: management items

    The company's items in this category are shown together, because filers word and number them differently.

    106 vote records from 58 filers. 0 of the 58 filers that marked the item voted against management.

    One filer reported a share count too large for the holding. The share split leaves those figures out; the counts of filers keep them. The rule

    • Positions of 26 fund families
    • For 26
  6. Item 6: OTHER: management items

    The company's items in this category are shown together, because filers word and number them differently.

    27 vote records from 8 filers. 0 of the 8 filers that marked the item voted against management.

    • Positions of 3 fund families
    • For 3

Positions of the fund families

A position is not the vote of each fund. The position of a family is the way most of the shares reported by its filers were voted. Funds of one family can vote in different ways.

KeyForAgainstAbstain or withholdSplit or no voteAgainst management

Fund families at Sino Biopharmaceutical Limited, meeting of 5 Jun 2024Families in name order. "Abstain" includes withhold. "Split" includes no vote. "No report" means that no filer of the family listed the item.
Fund family2. Auditor
American CenturyFor
BlackRock and iSharesFor
BNY MellonFor
Brighthouse FundsFor
Charles SchwabFor
DimensionalFor
EquitableFor
FidelityFor
Franklin TempletonFor
Goldman SachsFor
Hartford FundsFor
InvescoFor
J.P. MorganFor
Jackson National fundsFor
John Hancock and ManulifeFor
Lincoln FinancialFor
Morgan Stanley, Eaton Vance and CalvertFor
NationwideFor
Northern Trust and FlexSharesFor
Nuveen and TIAAFor
Pacific Life fundsFor
Russell InvestmentsFor
State Street and SPDRFor
ThriventFor
TransamericaFor
VanguardFor
Victory CapitalFor
VoyaFor
WisdomTreeFor

Questions

How many filers reported votes at the Sino Biopharmaceutical Limited meeting?
66 Form N-PX filers reported votes at the meeting of 5 Jun 2024.
Is this the result of the meeting?
No. The page counts the filers that report on Form N-PX, and the shares they reported. Sino Biopharmaceutical Limited reports the result of a vote on Form 8-K.
Why does the page show counts only for director elections?
A director record names the nominee. This site has no page and no row about a person. For director elections it keeps the number of nominees and the split of votes.

Provenance: SEC EDGAR, Form N-PX and N-PX/A filings that list Sino Biopharmaceutical Limited with a meeting date within three days of 5 Jun 2024. A proposal title is the most common wording among filers. Where a wording can name a person, the SEC category is shown. The filers wrote the filings. Filings read through .